title: Uncommon manifestation of a mixed-species malaria infection: cryptic falciparum malaria in a traveler with successfully treated tertian malaria.
abstract: We report a case of falciparum malaria in a traveler 9 days after successful treatment of ovale malaria. The underlying, cryptic mixed-species infection was primarily undetectable with standard laboratory diagnostics. This case highlights the limitations of these tests and the unpredictability of typical incubation periods in the individual case.
authors.affiliation: Institute of Tropical Medicine and International Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: Nikolai
authors.initials: N
authors.lastname: Menner
authors.forename: Matthias
authors.initials: M
authors.lastname: Borchert
authors.forename: Sebastian
authors.initials: S
authors.lastname: Dieckmann
authors.forename: Ralf
authors.initials: R
authors.lastname: Ignatius
authors.forename: Frank P
authors.initials: FP
authors.lastname: Mockenhaupt
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins / Q000008:administration & dosage*; D002738:Chloroquine / Q000008:administration & dosage*; D002846:Chromatography, Affinity / Q000379:methods; D060085:Coinfection / Q000097:blood / Q000188:drug therapy / Q000469:parasitology / Q000503:physiopathology; D004338:Drug Combinations; D057915:Drug Substitution / Q000379:methods; D004983:Ethanolamines / Q000008:administration & dosage*; D005449:Fluorenes / Q000008:administration & dosage*; D005858:Germany; D006801:Humans; D055256:Infectious Disease Incubation Period; D008288:Malaria / Q000097:blood / Q000188:drug therapy / Q000469:parasitology / Q000503:physiopathology; D008297:Male; D008853:Microscopy / Q000379:methods; D008875:Middle Aged; D009549:Nigeria; D018512:Parasitemia / Q000175:diagnosis; D010963:Plasmodium falciparum / Q000187:drug effects / Q000302:isolation & purification; D041122:Plasmodium ovale / Q000187:drug effects / Q000302:isolation & purification; D011319:Primaquine / Q000008:administration & dosage*; D014195:Travel; D016896:Treatment Outcome
chemical_list: D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D004338:Drug Combinations; D004983:Ethanolamines; D005449:Fluorenes; D002738:Chloroquine; D011319:Primaquine